Improving child growth through maternal egg consumption during pregnancy
DEUX OEUFs:Cracking the Potential of Eggs to Improve Child Growth and Development
NA · University of Florida · NCT06405360
This study is testing if pregnant women in Rwanda who eat two eggs a day can help their babies grow taller at birth compared to those who stick to their usual diet.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 1912 (estimated) |
| Ages | 18 Years to 44 Years |
| Sex | Female |
| Sponsor | University of Florida (other) |
| Locations | 1 site (Nyagatare) |
| Trial ID | NCT06405360 on ClinicalTrials.gov |
What this trial studies
This randomized controlled trial investigates the impact of maternal egg consumption on birth length among pregnant women in Rwanda. A total of 956 participants will be divided into two groups: one receiving two eggs daily and the other continuing their typical diet. The study aims to determine if increased egg intake during pregnancy can lead to improved birth outcomes, particularly in terms of infant growth and development. All participants will also receive standard nutritional education and care throughout the study period.
Who should consider this trial
Good fit: Ideal candidates are pregnant women aged 18-44 years, between 9-14 weeks gestation, living in the Nyagatare District of Rwanda.
Not a fit: Patients who are allergic to eggs or have conditions affecting their ability to comply with study requirements may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved birth lengths and overall child growth in malnourished populations.
How similar studies have performed: Previous studies have shown positive outcomes with dietary interventions in maternal nutrition, suggesting potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Lives in study area (catchment area of Karangazi Health Center and Ndama Health Center) * Confirmed viable intrauterine pregnancy (confirmed via ultrasound) * Aged between 18-44 years * 9-14 weeks gestation (confirmed via ultrasound, up to 13 weeks +6 days) * Agrees to participate with informed consent Exclusion Criteria: * Intention to move outside the study area in next 12 months * Intention to deliver at a location outside of Eastern Province Nyagatare District * Any known adverse reaction to eating eggs or porridge ingredients * Any condition that could affect the ability to comply with the study requirements or understand the informed consent process * Participation in other clinical trials (to avoid burden and potential interactions between interventions) * Any individual unable or unwilling to comply with the study requirements, such as attending regular follow-up visits or adhering to prescribed nutritional supplementation.
Where this trial is running
Nyagatare
- Ndama Health Center — Nyagatare, Rwanda (RECRUITING)
Study contacts
- Principal investigator: Sarah McKune, PhD, MPH — University of Florida
- Study coordinator: Sarah McKune, PhD, MPH
- Email: smckune@ufl.edu
- Phone: 3523280615
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Infant Malnutrition, Fetal Growth Retardation, Nutrition, Maternal Health, Infant growth and development, Maternal diet